The team is utilizing a synthetic biology approach to engineer a probiotic that can convert dietary glucose to glycogen to minimize or control insulin spikes in diabetic models.

Mark Kester
School of Medicine

Steven L. Zeichner
School of Medicine

Keith Kozminski
College and Graduate School of Arts & Sciences

Find out more: https://3c.virginia.edu/projects/107